BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21198702)

  • 21. Studies on furosemide: an effective oral saludiuretic for bilharzial ascites.
    Shafei AZ; Habib YA; el-Khangry HA; Abou-Khair SA; Abaza HH; Nibal AH
    J Trop Med Hyg; 1967 Dec; 70(12):286-92. PubMed ID: 6061451
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are metoclopramide and propranolol contraindicated, like nonsteroidal anti-inflammatory agents, in patients with cirrhosis and ascites?].
    Braillon A; Tribout B; Reix N; Capron JP
    Gastroenterol Clin Biol; 1986 Mar; 10(3):231-3. PubMed ID: 3732733
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.
    Tandon P; Tsuyuki RT; Mitchell L; Hoskinson M; Ma MM; Wong WW; Mason AL; Gutfreund K; Bain VG
    Liver Int; 2009 Feb; 29(2):169-74. PubMed ID: 18492024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.
    Singh V; Dheerendra PC; Singh B; Nain CK; Chawla D; Sharma N; Bhalla A; Mahi SK
    Am J Gastroenterol; 2008 Jun; 103(6):1399-405. PubMed ID: 18547224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new diuretic: Furosemide. Its effect on bilahariasis-cirrhosis with ascites].
    el Badry A; el Ayadi ; el Safori S; Topuzada S
    Med Monatsschr; 1965 Oct; 19(10):463-6. PubMed ID: 5882442
    [No Abstract]   [Full Text] [Related]  

  • 28. Bumetanide in refractory ascites of cirrhosis of the liver: a comparison with furosemide.
    Iber FL; Baum RA
    J Clin Pharmacol; 1981; 21(11):697-700. PubMed ID: 7338581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
    Mansurov KhKh; Dustov AD
    Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis.
    Dao MT; Villeneuve JP
    Clin Invest Med; 1988 Feb; 11(1):6-9. PubMed ID: 3365882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Furosemide therapy in "intractable ascites".
    Steigmann F; Oz R; De Will P; Dubin A
    Am J Med Sci; 1966 Oct; 252(4):436-41. PubMed ID: 5922491
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of diuretics on chronic liver disease.
    Steigmann F; Mejicano R
    Am J Gastroenterol; 1969 Jul; 52(1):37-44. PubMed ID: 5796683
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V; Porcellati C; Corea L; Todisco T
    Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
    [No Abstract]   [Full Text] [Related]  

  • 35. The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.
    Toniutto P; Pirisi M; Fabris C; Apollonio L; Sereti K; Bartoli EG
    Dig Dis Sci; 2006 Nov; 51(11):1992-7. PubMed ID: 17053959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT.
    Ashritha A; Lal BB; Khanna R; Sood V; Sood AK; Alam S
    J Pediatr Gastroenterol Nutr; 2024 Feb; 78(2):350-359. PubMed ID: 38374552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G; Lazzaroni M; Petrillo M
    Nouv Presse Med; 1975 Apr; 4(14):1043. PubMed ID: 1093119
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis.
    Guo TT; Yang Y; Song Y; Ren Y; Liu ZX; Cheng G
    J Dig Dis; 2016 Jan; 17(1):11-9. PubMed ID: 26630543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Demeclocycline: a new treatment of water-salt retention in cirrhosis and refractory ascites].
    Poupon R; Gustot P; Darnis F
    Nouv Presse Med; 1976 Sep; 5(31):1993-4. PubMed ID: 824615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.